An Open-Label, Multicenter, Multinational, Study of the Safety, Efficacy,Pharmacokinetics, and Pharmacodynamics of RecombinantHumanAcid alpha-Glucosidase (rhGAA) Treatment in Patients > 6 and <= 36 Months Old with Infantile-OnsetPompe Disease (Glycogen Storage Disease Type II) An Open-Label, Multicenter, Multinational, Study of the Safety, Efficacy,Pharmacokinetics, and Pharm ...
An Open-Label, Multicenter, Multinational, Study of the Safety, Efficacy,Pharmacokinetics, and Pharmacodynamics of RecombinantHumanAcid alpha-Glucosidase (rhGAA) Treatment in Patients > 6 and <= 36 Months Old with Infantile-OnsetPompe Disease (Glycogen Storage Disease Type II) An Open-Label, Multicenter, Multinational, Study of the Safety, Efficacy,Pharmacokinetics, and Pharm ...
Treatment for Type II Glycogenosis MedDRA version: 6.1;Level: PT;Classification code 10053185
Product Name: Recombinanthumanacidalfa-glucosidase(rhGAA) Product Code: NA INN or Proposed INN: alglucosidase alfa Product Name: Recombinanthumanacidalfa-glucosidase(rhGAA) Product Code: NA INN or Proposed INN: alglucosidase alfa Product Name: Recombinanthumanacidalfa-glucosidase(rhGAA) Product Code: NA INN or Proposed INN: al ...